{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:48:12Z","timestamp":1790020092618,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301598"],"award-info":[{"award-number":["82301598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822016"],"award-info":[{"award-number":["81822016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271447"],"award-info":[{"award-number":["82271447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jneuroim.2026.578968","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:18:23Z","timestamp":1778728703000},"page":"578968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The TLR4\/NF-\u03baB\/NLRP3 pathway is involved in levofloxacin-induced alleviation of neuroinflammation in Parkinson's disease"],"prefix":"10.1016","volume":"418","author":[{"given":"Xingyue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.jneuroim.2026.578968_bb0005","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111643118","article-title":"Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease","volume":"118","author":"Ahuja","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.jneuroim.2026.578968_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson\u2019s disease-from neurodegeneration to therapeutic opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578968_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094676","article-title":"The contribution of microglia to neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10291","key":"10.1016\/j.jneuroim.2026.578968_bb0020","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578968_bb0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","article-title":"Tetracycline repurposing in neurodegeneration: focus on Parkinson\u2019s disease","volume":"125","author":"Bortolanza","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578968_bb0030","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/cid\/ciae093","article-title":"Central nervous system antimicrobial exposure and proposed dosing for anthrax meningitis","volume":"78","author":"Bradley","year":"2024","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578968_bb0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/17460441.2018.1429400","article-title":"Advances in prodrug design for Parkinson\u2019s disease","volume":"13","author":"Cacciatore","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/cns.13989","article-title":"Multiple drug transporters contribute to the brain transfer of levofloxacin","volume":"29","author":"Cen","year":"2022","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578968_bb0045","doi-asserted-by":"crossref","DOI":"10.26599\/FSHW.2024.9250066","article-title":"Effect of purine diet on prognosis of deep brain stimulation for Parkinson\u2019s disease","volume":"14","author":"Chang","year":"2025","journal-title":"Food Sci. Human Wellness"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0050","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578968_bb0055","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2026.578968_bb0060","first-page":"72","article-title":"Vancomycin pretreatment on MPTP-induced Parkinson\u2019s disease mice exerts neuroprotection by suppressing inflammation both in brain and gut","volume":"18","author":"Cui","year":"2022","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"22","key":"10.1016\/j.jneuroim.2026.578968_bb0065","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","article-title":"The role of inflammation in sporadic and familial Parkinson\u2019s disease","volume":"70","author":"Deleidi","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.578968_bb0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/47.5.611","article-title":"Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model","volume":"47","author":"Destache","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578968_bb0075","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40265-022-01747-7","article-title":"Newly approved and investigational drugs for motor symptom control in Parkinson\u2019s disease","volume":"82","author":"Di Luca","year":"2022","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578968_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14489","article-title":"A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response","volume":"30","author":"Duan","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578968_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/WNF.0000000000000182","article-title":"Does levofloxacin improve parkinsonian features or is the improvement only coincidental?","volume":"39","author":"El Ayoubi","year":"2016","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2026.578968_bb0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neuropharm.2017.08.002","article-title":"Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathology","volume":"128","author":"Gustafsson","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578968_bb0095","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"issue":"23","key":"10.1016\/j.jneuroim.2026.578968_bb0100","doi-asserted-by":"crossref","first-page":"13693","DOI":"10.1021\/acs.chemrev.3c00479","article-title":"Parkinson\u2019s disease: advances in treatment and the syntheses of various classes of pharmaceutical drug substances","volume":"123","author":"Hill","year":"2023","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40168-020-00988-6","article-title":"Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease","volume":"9","author":"Hou","year":"2021","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13020-023-00745-5","article-title":"A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an example","volume":"18","author":"Hu","year":"2023","journal-title":"Chin. Med."},{"key":"10.1016\/j.jneuroim.2026.578968_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2025.116267","article-title":"A study of bidirectional control of Parkinson\u2019s beta oscillations by basal ganglia","volume":"195","author":"Hu","year":"2025","journal-title":"Chaos, Solitons Fractals"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.578968_bb0120","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/10286020.2024.2371040","article-title":"Mechanisms and therapeutic potential of chinonin in nervous system diseases","volume":"26","author":"Hui","year":"2024","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578968_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578968_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00018-022-04450-8","article-title":"Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model","volume":"79","author":"Januel","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2026.578968_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578968_bb0145","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s11011-022-00999-2","article-title":"Emerging targets signaling for inflammation in Parkinson\u2019s disease drug discovery","volume":"37","author":"Khairnar","year":"2022","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578968_bb0150","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1096\/fj.201802554RRR","article-title":"Drosophila SMN2 minigene reporter model identifies moxifloxacin as a candidate therapy for SMA","volume":"34","author":"Konieczny","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2026.578968_bb0155","article-title":"Gait improvement after levofloxacin administration in a progressive supranuclear palsy patient","volume":"3","author":"Kurihara","year":"2020","journal-title":"Clin. Parkinsonism Relat. Disord"},{"key":"10.1016\/j.jneuroim.2026.578968_bb0160","article-title":"Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-025-03461-z","article-title":"Rebamipide (Mucosta\u00ae), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson\u2019s disease model","volume":"22","author":"Lim","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.578968_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00395","article-title":"Apelin-13 suppresses neuroinflammation against cognitive deficit in a Streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578968_bb0175","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/cns.14063","article-title":"Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson\u2019s disease by inhibiting microglial activation via the TLR4\/Myd88\/NF-KB pathway","volume":"29","author":"Lv","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jneuroim.2026.578968_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.119480","article-title":"Metabolic modulation by antibiotic levofloxacin alters Cis-bifenthrin-induced neurotoxicity in amphibian tadpoles","volume":"308","author":"Ma","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"22","key":"10.1016\/j.jneuroim.2026.578968_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578968_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejps.2018.06.018","article-title":"Pharmacokinetics of pericyte involvement in small-molecular drug transport across the blood-brain barrier","volume":"122","author":"Mihajlica","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578968_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578968_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062419","article-title":"9-Hydroxyaristoquinolone: a new indole alkaloid isolated from Aristotelia chilensis with inhibitory activity of NF-\u03baB in HMC-3 microglia cells","volume":"26","author":"P\u00e9rez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317281","article-title":"Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: inhibition of proinflammatory cytokine release, TLR4\/STAT3, and ERK\/NF-\u03baB signaling pathway","volume":"20","author":"Phuagkhaopong","year":"2025","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.578968_bb0210","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/glia.24260","article-title":"Microglial AIM2 alleviates antiviral-related neuro-inflammation in mouse models of Parkinson's disease","volume":"70","author":"Rui","year":"2022","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.jneuroim.2026.578968_bb0215","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1086\/323406","article-title":"Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis","volume":"33","author":"Scotton","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"9\u201310","key":"10.1016\/j.jneuroim.2026.578968_bb0220","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s10495-025-02148-3","article-title":"Targeting ASK1 signaling in neurodegeneration: molecular insights and therapeutic promise","volume":"30","author":"Sulthana","year":"2025","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578968_bb0225","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","article-title":"The reciprocal interactions between microglia and T cells in Parkinson\u2019s disease: a double-edged sword","volume":"20","author":"Xu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.578968_bb0235","article-title":"Levofloxacin alleviates blood-brain barrier disruption following cerebral ischemia and reperfusion via directly inhibiting A-FABP","volume":"963","author":"Yang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578968_bb0240","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2026.578968_bb0245","article-title":"Edaravone dexborneol protected neurological function by targeting NRF2\/ARE and NF-\u03baB\/AIM2 pathways in cerebral ischemia\/reperfusion injury","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578968_bb0250","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5526","article-title":"Ceftriaxone affects ferroptosis and alleviates glial cell activation in Parkinson\u2019s disease","volume":"55","author":"Zhi","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578968_bb0255","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-019-1538-9","article-title":"Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway","volume":"16","author":"Zusso","year":"2019","journal-title":"J. Neuroinflammation"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:19:06Z","timestamp":1786349946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"alternative-id":["S0165572826001165"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578968","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TLR4\/NF-\u03baB\/NLRP3 pathway is involved in levofloxacin-induced alleviation of neuroinflammation in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578968"}}